Emerging Technologies in Cell and Gene therapy
This EU funding program, "Emerging Technologies in Cell and Gene therapy" (HORIZON-EIC-2021-PATHFINDERCHALLENGES-01-03), aims to advance breakthrough technologies in cell and gene therapy. It supports pioneering research projects from concept to proof-of-principle, reinforcing Europe's competitiveness in this critical biomedical field. The program specifically targets innovative solutions that overcome current challenges in cell and gene therapy, moving beyond the state-of-the-art.
Who is Funded
This section details the eligibility criteria for applicants, the geographical scope of the program, and its overarching objectives, focusing on fostering innovation in cell and gene therapy across Europe.
What is Funded
This section outlines the specific types of projects and thematic areas eligible for funding, emphasizing emerging technologies in cell and gene therapy. It also clarifies the typical developmental stage of supported projects and expected outputs.
Type and Scope of Funding
This section clarifies the nature of financial support provided through the EIC Pathfinder Challenges, specifically identifying it as grant funding. It also touches upon the project duration and the overall program period.
Conditions and Requirements
This section outlines the essential conditions and requirements for applicants, covering application submission, consortium formation, and other important provisions that ensure compliance and effective project implementation.
Application Procedure
This section details the systematic steps involved in submitting a proposal, from preparation to the evaluation and award process, and outlines how successful applicants are informed.
Legal Basis
This section identifies the core legal and official documents that establish and govern the "Emerging Technologies in Cell and Gene therapy" funding program, ensuring transparency and compliance.
Similar Programs
Funding Overview
Funding Status:
Closed
Open Until:
31.12.2027
Award Channel:
Framework Programme Call
Region:
EU Member States and Associated Countries
Sectors:
Healthcare, Medical Technology, Research and Development, Pharmaceutical Industry
Beneficiaries:
Healthcare
Application Type:
Optional Consortium
Funding Stages:
Basic Research, Applied Research, Experimental Development, Prototyping
Funding Provider
Program Level:
European Union
Funding Body:
European Commission
Managed By:
European Innovation Council (EIC)
Website: